1. Home
  2. MATV vs TBPH Comparison

MATV vs TBPH Comparison

Compare MATV & TBPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MATV
  • TBPH
  • Stock Information
  • Founded
  • MATV 1995
  • TBPH 2013
  • Country
  • MATV United States
  • TBPH United States
  • Employees
  • MATV N/A
  • TBPH N/A
  • Industry
  • MATV Paper
  • TBPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • MATV Basic Materials
  • TBPH Health Care
  • Exchange
  • MATV Nasdaq
  • TBPH Nasdaq
  • Market Cap
  • MATV 669.7M
  • TBPH 699.0M
  • IPO Year
  • MATV 1995
  • TBPH N/A
  • Fundamental
  • Price
  • MATV $12.44
  • TBPH $13.95
  • Analyst Decision
  • MATV Strong Buy
  • TBPH Strong Buy
  • Analyst Count
  • MATV 1
  • TBPH 3
  • Target Price
  • MATV $10.00
  • TBPH $21.33
  • AVG Volume (30 Days)
  • MATV 794.6K
  • TBPH 579.1K
  • Earning Date
  • MATV 11-05-2025
  • TBPH 08-12-2025
  • Dividend Yield
  • MATV 3.27%
  • TBPH N/A
  • EPS Growth
  • MATV N/A
  • TBPH N/A
  • EPS
  • MATV N/A
  • TBPH 0.26
  • Revenue
  • MATV $1,967,300,000.00
  • TBPH $77,205,000.00
  • Revenue This Year
  • MATV $3.68
  • TBPH $78.36
  • Revenue Next Year
  • MATV $2.82
  • TBPH N/A
  • P/E Ratio
  • MATV N/A
  • TBPH $54.91
  • Revenue Growth
  • MATV N/A
  • TBPH 24.49
  • 52 Week Low
  • MATV $4.34
  • TBPH $7.88
  • 52 Week High
  • MATV $19.96
  • TBPH $14.55
  • Technical
  • Relative Strength Index (RSI)
  • MATV 72.96
  • TBPH 71.41
  • Support Level
  • MATV $11.87
  • TBPH $13.66
  • Resistance Level
  • MATV $12.61
  • TBPH $14.55
  • Average True Range (ATR)
  • MATV 0.50
  • TBPH 0.46
  • MACD
  • MATV -0.11
  • TBPH -0.02
  • Stochastic Oscillator
  • MATV 75.27
  • TBPH 56.20

About MATV Mativ Holdings Inc.

Mativ Holdings Inc is a diversified producer of premium specialty papers and resin-based products. It manufactures and sells paper and reconstituted tobacco products to the tobacco industry as well as specialized paper products. The company operates in two segments namely Advanced Materials and Structures, which manufactures resin-based products used in specialty applications in the filtration, infrastructure and construction, transportation, industrial, and medical end-markets, and Engineered Papers, which produces cigarette papers and reconstituted tobacco products for cigarette and cigar manufacturers, as well as various other non-tobacco paper products.

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

Share on Social Networks: